EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.

Law firm Kirby McInerney LLP is investigating Embecta Corp. following the company's May 5, 2026 earnings report that missed analyst expectations and included reduced full-year guidance. The announcement cited losses in pen needle products at a major customer and market softness in insulin pens. Embecta's stock price plummeted 58% from $9.25 to $3.90 per share on the news. The investigation seeks to determine if federal securities laws were violated.